Toxoplasmosis, caused by the apicomplexan parasite Toxoplasma gondii, is one of the most
damaging parasite-borne zoonotic diseases of global importance. While approximately one …

Toxoplasma gondii host cellular invasion factors such as the rhoptry proteins, micronemal
antigens, or other subcellular compartment proteins have shown limited vaccine efficacies …

Aim: To evaluate the protective efficacy induced by heterologous immunization with
recombinant baculoviruses or virus-like particles targeting the CST1 and ROP18 antigens of …

Pathogens require physical contact with the mucosal surface of the host organism to initiate
infection and as such, vaccines eliciting both mucosal and systemic immune responses …

Toxoplasma gondii (T. gondii) that can infect most warm-blooded animals and humans, is an
obligate intracellular apicomplexan parasite with a wide host range. About one-third of the …

Avian influenza virus remains a threat for humans, and vaccines preventing both avian and
human influenza virus infections are needed. Since virus-like particles (VLPs) expressing …

Heterologous prime–boost immunization regimens using various vaccine platforms
demonstrated promising results against infectious diseases. Here, mice were sequentially …

Nanoparticles are significant for veterinary vaccine development because they are safer and
more effective than conventional formulations. One promising area of research involves self …

Passive immunity can provide immediate protection against infectious pathogens. To date,
only a few studies have investigated the effect of passive immunization against Toxoplasma …

Toxoplasma gondii is an intracellular parasitic organism affecting all warm-blooded
vertebrates. Due to the unavailability of commercialized human T. gondii vaccine, many …